Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
GR Foster, N Afdhal, SK Roberts, N Braeu, EJ Gane, S Pianko, E Lawitz, A Thompson, ML Shiffman, C Cooper, WJ Towner, B Conway, P Ruane, M Bourliere, T Asselah, T Berg, S Zeuzem, W Rosenberg, K Agarwal, CAM Stedman Show all
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2015
Awarded by National Institute for Health Research
Funded by Gilead Sciences; ASTRAL-2 ClinicalTrials.gov number, NCT02220998; and ASTRAL-3, NCT02201953.